A multilevel intervention improved human papillomavirus vaccine initiation and completion among most children aged 11 to 12 years, though the effect was limited for those living in under-resourced settings,...
New research shows stalled childhood vaccine progress, elevated heart risks linked to COVID-19 vaccines in young men, and rising gastrointestinal disorders during the pandemic.
A national analysis of county-level measles-mumps-rubella vaccination rates from 2017 to 2024 shows a significant decline following the COVID-19 pandemic, with geographic variation and implications for...
Secretary Robert F. Kennedy Jr. announced that the CDC will no longer recommend the COVID-19 booster vaccine for healthy children and pregnant people. The announcement comes despite previous CDC...
New research explores long COVID risks in children, ACIP's expanded RSV vaccine use, U.S. disease resurgence under falling immunization, and long COVID’s burden on health care workers.
A prospective study assessed opioid-free anesthesia during total shoulder arthroplasty and found lower in-hospital opioid use and pain scores. This study will be presented on May 2, 2025, at the ASRA Annual...
A phase 3 study found that the 20-valent pneumococcal conjugate vaccine (PCV20) elicited strong immune responses across all 20 serotypes and had a safety profile comparable with PCV13.
A randomized trial comparing influenza vaccines over two seasons found that recombinant vaccines showed stronger immune responses to A/H3N2 strains compared with egg-based and cell culture-based vaccines.
...
The CDC has updated its guidelines for COVID-19 and pneumococcal vaccines, aiming to boost protection for high-risk populations against severe disease year-round.
Researchers aimed to describe the most common symptoms of long COVID and the progression of symptoms over time. They presented their findings at IDWeek 2023 in Boston, Massachusetts.
